In the last trading session, 0.12 million HCW Biologics Inc (NASDAQ:HCWB) shares changed hands as the company’s beta touched 0.90. With the company’s per share price at $0.40 changed hands at $0.0 or -0.20% during last session, the market valuation stood at $15.05M. HCWB’s last price was a discount, traded about -530.0% off its 52-week high of $2.52. The share price had its 52-week low at $0.28, which suggests the last value was 30.0% up since then. When we look at HCW Biologics Inc’s average trading volume, we note the 10-day average is 0.41 million shares, with the 3-month average coming to 9.22 million.
HCW Biologics Inc (NASDAQ:HCWB) trade information
Instantly HCWB was in red as seen at the end of in last trading. With action 20.17%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -67.51%, with the 5-day performance at 20.17% in the green. However, in the 30-day time frame, HCW Biologics Inc (NASDAQ:HCWB) is -48.31% down. Looking at the short shares, we see there were 8092.0 shares sold at short interest cover period of 0.28 days.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
HCW Biologics Inc (HCWB) estimates and forecasts
Year-over-year growth is forecast to reach 222.75% up from the last financial year.
Consensus estimates given by 1 financial analysts project the company’s revenue in the current quarter to hit an average of 7M. The company’s revenue for the corresponding quarters a year ago was 1.32M. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 428.70%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -34.57%. The 2024 estimates are for HCW Biologics Inc earnings to increase by 18.57%.
HCWB Dividends
HCW Biologics Inc is expected to release its next quarterly earnings report in January.
HCW Biologics Inc (NASDAQ:HCWB)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 52.30% of HCW Biologics Inc shares while 3.13% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 6.56%. There are 3.13% institutions holding the HCW Biologics Inc stock share, with AVANTAX PLANNING PARTNERS, INC. the top institutional holder. As of 2024-06-30, the company held 0.751% of the shares, roughly 0.28 million HCWB shares worth $0.18 million.
HIGHTOWER ADVISORS, LLC holds the second largest percentage of outstanding shares, with 0.4857% or 0.18 million shares worth $0.12 million as of 2024-06-30.
